106 related articles for article (PubMed ID: 24358681)
1. [Telmisartan and valsartan].
Perspect Infirm; 2013; 10(5):63. PubMed ID: 24358681
[No Abstract] [Full Text] [Related]
2. Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan.
Volpe M
Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):1061-72. PubMed ID: 23030295
[TBL] [Abstract][Full Text] [Related]
3. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
White WB; Lacourciere Y; Davidai G
Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
[TBL] [Abstract][Full Text] [Related]
4. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
White WB; Davidai G; Schumacher H
J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Yamagishi S; Takeuchi M
Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin receptor blockers and myocardial infarction.
Verma S; Strauss M
BMJ; 2004 Nov; 329(7477):1248-9. PubMed ID: 15564232
[No Abstract] [Full Text] [Related]
7. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
Scholze J; Müller U
MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
[No Abstract] [Full Text] [Related]
8. Angioedema due to valsartan.
Martínez Alonso JC; Domínguez Ortega FJ; Méndez Alcalde J; Fuentes Gonzalo MJ
Allergy; 2003 Apr; 58(4):367. PubMed ID: 12708991
[No Abstract] [Full Text] [Related]
9. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
[TBL] [Abstract][Full Text] [Related]
10. Linear lichenoid drug eruption induced by valsartan.
Gencoglan G; Ceylan C; Kazandi AC
Clin Exp Dermatol; 2009 Oct; 34(7):e334-5. PubMed ID: 19456765
[No Abstract] [Full Text] [Related]
11. Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review.
Lacourcière Y
Clin Exp Hypertens; 2013; 35(1):50-60. PubMed ID: 22866964
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.
Luzio SD; Dunseath G; Owens DR
Horm Metab Res; 2002 May; 34(5):271-4. PubMed ID: 12063642
[TBL] [Abstract][Full Text] [Related]
14. Lithium intoxication after valsartan treatment.
Su YP; Chang CJ; Hwang TJ
Psychiatry Clin Neurosci; 2007 Apr; 61(2):204. PubMed ID: 17362443
[No Abstract] [Full Text] [Related]
15. [Acute hepatitis induced by valsartan].
Reñé JM; Buenestado J; Sesé E; Miñana JM
Med Clin (Barc); 2001 Nov; 117(16):637-8. PubMed ID: 11714476
[No Abstract] [Full Text] [Related]
16. [Angioedema and urticarial reaction induced by valsartan].
de la Serna Higuera C
Med Clin (Barc); 2000 Apr; 114(15):599. PubMed ID: 10846683
[No Abstract] [Full Text] [Related]
17. Nightmares induced by valsartan.
Kastalli S; El AS; Loueslati MH; Daghfous R; Belkahia C
Therapie; 2006; 61(1):81-2. PubMed ID: 16792161
[No Abstract] [Full Text] [Related]
18. Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice.
Ushijima K; Takuma M; Ando H; Ishikawa-Kobayashi E; Nozawa M; Maekawa T; Shiga T; Fujimura A
Eur J Pharmacol; 2013 Jan; 698(1-3):505-10. PubMed ID: 23195328
[TBL] [Abstract][Full Text] [Related]
19. The occurrence rate of cerebrovascular and cardiac events in patients receiving antihypertensive therapy from the post-marketing surveillance data for valsartan in Japan (J-VALID).
Yamazaki T; Kohro T; Chujo M; Ishigaki M; Hashimoto T
Hypertens Res; 2013 Feb; 36(2):140-50. PubMed ID: 23096231
[TBL] [Abstract][Full Text] [Related]
20. Second study on valsartan is threatened with retraction over alleged data manipulation.
Mahony C
BMJ; 2013 Aug; 347():f4920. PubMed ID: 23918698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
